Inventory management systems       

Inventory management systems        image

Home » FOI request log » Inventory management systems       

FOI REFERENCE: 24509  FOI DATE: 8th November 2024       

Please may you provide me with answers to the following: 

  1. Does your Trust use an Inventory Management System (IMS)? Yes
  1. If ‘Yes,’ which company supplies this?    Ingenica
  2. If ‘No, do you have plans to procure an IMS within the next three years?

If the answer to Question 1 was yes, then: 

  1. Which company supplies the IMS? Ingenica
  2. When was this system implemented? 20/04/2023
  3. When was the most recent upgrade or change? 23/01/2024
  4. Did you procure this system independently, through NHS Supply Chain, or through some other route (please specify)? Framework.
  5. Did the Trust use a different IMS prior to the current one? If so, please specify the previous system(s) and how long were they used for? No.
  6. What are the key differences between the current IMS and any previous IMS in terms of functionality, ease of use, and integration with other Trust systems? Not applicable
  7. Does the current system manage the following: 

High-cost implants (e.g., cardiac pacemakers, hip and knee replacements, spinal fusion devices) Yes

Consumables (e.g., scalpels, blood vials, swabs) Yes

Human tissue (e.g., corneal tissue, skin grafts, bone grafts, heart valves) Yes

    1. Does your IMS integrate with other Trust software (e.g., EPR, procurement platforms)? If yes, which? Yes, SBS iProc and GHX Nexus.
    2. What primary benefits has the Trust observed with the current IMS (e.g., cost savings, efficiency gains, regulatory compliance)? Cost savings, efficiency gains, regulatory compliance.
    3. Do you believe that you are receiving/expect to have received by the contract end good return on investment from this IMS? Yes
    4. What are the main challenges or limitations experienced with the system? Reliability
    5. Does the Trust have plans to upgrade or replace the IMS within the next three years? No
    6. What new capabilities/improvements/features would be a priority in future IMS procurement (e.g., enhanced traceability, asset or human tissue tracking)? Loan kit tracking.
    7. Who is the best person within the Trust to speak to about IMS systems? Procurement Director [email protected] 
    Print this page
    Email this page